NOTV: Inotiv Corp EV/EBITDA Multiple

Symbol and logo of brand Inotiv (NOTV)

Inotiv, Inc. (NOTV) faces severe pressure due to debt obligations and US restrictions on primate imports. However, the recovery of biotech R&D budgets and the expansion of laboratories are driving the growth of this CRO. The linear price action on the EV/EBITDA chart is recorded at 0.00. The business relies on external suppliers for feed and reagents, creating a significant dependency on the reliability of partners' supply chains.

NOTV Inotiv Corporation: Total Company Value to Operating Income Before Depreciation Ratio in the range 11/23/2025 - 06/21/2026

Analytical breakdowns for Inotiv, Inc.

- stock price and consensus target price:
Stock Quotes Inotiv Corp|NOTV - Analyst Forecast Prices
- market capitalization information:
Market Capitalization Inotiv Corporation|NOTV - Total Enterprise Value
- issuer book value statistics:
Net Assets per Single Share Inotiv|NOTV - Book Valuation of Business|Market Cap to Net Assets Ratio inotivco.com|NOTV - Aggregate Business Assets
- debt and liquidity data:
Debt to Equity Inotiv, Inc.|NOTV - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Inotiv|NOTV - Company Total Debt Obligations|Debt to Book Capitalization Ratio Inotiv Corporation|NOTV - Company Long-Term Indebtedness|Company Short-Term Debt Inotiv|Quick Liquidity Indicator inotivco.com
- business earnings and investment ratios data:
NOTV - Profit After Payment of Taxes|Projected Future Earnings Inotiv, Inc.|NOTV - Business Payback Period|Projected Price to Earnings Inotiv, Inc.|NOTV - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Inotiv Corporation|NOTV - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Inotiv|NOTV - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months inotivco.com|NOTV - Earnings per share growth this year|Earnings growth forecast for next year Inotiv, Inc.
Comprehensive company analysis:NOTV (Inotiv Corp)
Original product of inotivco.com

This indicator correlates the total enterprise value, including net debt, to earnings before interest, taxes, depreciation, and amortization, allowing for an assessment of the real value of assets without the influence of taxes and debt load. By analyzing the EV/EBITDA chart, investors determine whether the asset is overbought, which is critical for Inotiv, Inc. (NOTV) amid geopolitical market fragmentation and the disruption of laboratory material supply chains.

Competitor analysis for Inotiv, Inc.

IQVIA Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio LH (LabCorp)|Medpace Holdings, Inc. - EV/EBITDA Multiple|Company Value to EBITDA ICON Public Limited Company|Charles River (CRL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|EVO - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio FTRE|LFCR (Lifecore) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OmniAb, Inc. (OABI)|Total Company Value to Operating Income Before Depreciation Ratio avidbio.com|EV/EBITDA Multiple CTLT (Catalent)|Total Company Value to Operating Income Before Depreciation Ratio Scorpius Holdings Inc. (SCPX)